Page last updated: 2024-10-18

imidazole and Cardiomyopathy, Chagas

imidazole has been researched along with Cardiomyopathy, Chagas in 1 studies

imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

Research Excerpts

ExcerptRelevanceReference
"People with Chagas disease (American Trypanosomiasis) may develop progressive and potentially lethal heart conditions."2.43Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection). ( Reyes, PA; Vallejo, M, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reyes, PA1
Vallejo, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Double Blind Clinical Trial[NCT02386358]Phase 3910 participants (Actual)Interventional1999-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for imidazole and Cardiomyopathy, Chagas

ArticleYear
Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
    The Cochrane database of systematic reviews, 2005, Oct-19, Issue:4

    Topics: Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Clinical Trials as Topic; Humans; Imidazoles

2005